Chemical Compound

tunicamycin V

CAS Registry Number 66054-36-2
tunicamycin V chemical structure
Primary Record

tunicamycin V

In stock
4,347 g
Purity
98.9 %
CAS
66054-36-2

Compound Identifiers & Properties

CAS
66054-36-2
PubChem CID
11104835
SMILES
CC(C)CCCCCCCCC/C=C/C(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)NC(=O)C)C[C@H]([C@@H]3[C@H]([C@H]([C@@H](O3)N4C=CC(=O)NC4=O)O)O)O)O)O
Canonical SMILES
CC(=O)N[C@H]1[C@@H](O[C@@H]2O[C@H](C[C@@H](O)[C@H]3O[C@@H](n4ccc(=O)[nH]c4=O)[C@H](O)[C@@H]3O)[C@H](O)[C@H](O)[C@H]2NC(=O)/C=C/CCCCCCCCCC(C)C)O[C@H](CO)[C@@H](O)[C@@H]1O

Names & Synonyms

  • tunicamycin V
  • tunicamycin A
  • Tunicamycin B2
  • tunicamycin
  • Tunicamycin B1
  • (+)-Tunicamycin V
  • RefChem:933648
  • UNII-17RV2Q5O9O
  • Tunicamycin 15:1 Mixture
  • 17RV2Q5O9O
  • CHEMBL4534172
  • CHEBI:64250
  • DTXSID601017533
  • SCHEMBL21597952
  • GTPL13510
  • 66054-36-2
  • DTXCID101475722
  • HY-N8395
  • BDBM50537412
  • ZINC96085312
  • AKOS040756343
  • CID11104835
  • CID 11104835
  • DA-68419
  • Tunicamycin V, >=95% (LC/MS-ELSD)
  • J571.556C
  • CS-0143906
  • F82788
  • A1035934
  • Q27133159
  • (E)-N-[(2S,3R,4R,5R,6R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-13-methyltetradec-2-enamide
  • 73942-09-3
  • (2E)-N-[(2S,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-6-{(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-2-hydroxyethyl}-4,5-dihydroxytetrahydro-2H-pyran-3-yl]-13-methyltetradec-2-enamide
  • (5'R)-5'-[2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1<->1)-2,6-dideoxy-2-(13-methyltetradec-2-enamido)-beta-D-galactopyranos-6-yl]uridine
  • (E)-N-[2-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]pentadec-2-enamide
  • (2E)-N-((2S,3R,4R,5R,6R)-2-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-((2R)-2-((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl)-4,5-dihydroxytetrahydro-2H-pyran-3-yl)-13-methyltetradec-2-enamide;(5'R)-5'-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(11)-2,6-dideoxy-2-(13-methyltetradec-2-enamido)-beta-D-galactopyranos-6-yl)uridine
  • (2E)-N-[(2S,3R,4R,5R,6R)-2-{[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-{(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl}-4,5-dihydroxyoxan-3-yl]-13-methyltetradec-2-enamide
  • (2E)-N-[(2S,3R,4R,5R,6R)-6-[(2R)-2-[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl]-2-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5-dihydroxyoxan-3-yl]-13-methyltetradec-2-enamide
  • 1-[(11S)-11-O-(2-Acetylamino-2-deoxy-alpha-D-glucopyranosyl)-10-deoxy-10-[[(E)-13-methyl-1-oxo-2-tetradecenyl]amino]-L-galacto-beta-D-allo-undecodialdo-1,4-furanose-11,7-pyranose-1-yl]pyrimidine-2,4(1H,3H)-dione
  • 9LH